#

Ulcerative Colitis

  • Compensation to be determined
  • 17 study visits
#

18+ Years

#
Male or Female
#
Smoker & Non-Smoker

Description

UC Study 1

This is a 34-week Phase 2 study testing the safety, effectiveness, and other properties of an investigational product in people with moderate to severe ulcerative colitis.

UC Study 2

This 52-week study evaluates the safety and effectiveness of an investigational product in patients with moderate to severe ulcerative colitis.

Is this not what you are looking for?
Check out our other studies.

Related Studies

#

Non-alcoholic steatohepatitis (NASH)

  • Compensation to be determined
  • 18 study visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
#

Metabolic dysfunction-associated steatohepatitis (MASH)

  • Compensation to be determined
  • 18 study visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
#

Venous Leg Ulcer

  • Compensation to be determined
  • 13 study visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
© 2024 Access Research Institute. All Rights Reserved